300194 Fuan Pharmaceutical
- 4.99
- -0.16-3.11%
About Fuan Pharmaceutical Company
The company was founded on February 25, 2004, and is the first enterprise successfully listed on the Shenzhen GEM in Changshou Economic and Technological Development Zone. It was successfully listed on the Shenzhen Stock Exchange GEM on March 22, 2011. The company is mainly engaged in R&D, production and sales of chemicals. The company's main products are: gentamicin, cefazoxime sodium, cefmetazol sodium, laoxicefin, ceftazidime, torrimifene citrate tablets (preparation), ondansetron hydrochloride (APIs, preparations), doxochylline (active ingredients, preparations), nimegoline capsules, sulinic acid tablets, glutathione. Corporate honors: 2008 - National Key New Products; 2009 - Master's Student Practice Base; 2011 - National Key High-tech Enterprise; 2016 - High-tech Enterprise, “China's Top 100 Pharmaceutical Industry Enterprises” at the National Pharmaceutical Industry Information Annual Conference, “Top 100 Chinese Pharmaceutical R&D Comprehensive Strength” at the 5th China Pharmaceutical R&D Innovation Summit, and “China's Top 50 Chemical Pharmaceutical R&D Capabilities”.
Company Profile
Company Executives
- Name
- Position
- Salary
- tianxiang wang
- Chairman, Directors, Chairman of the Strategy Committee, Nomination Committee Members, Member of the Remuneration and Assessment Committee
- 919.80K
- tao huang
- Vice Chairman, Directors, Deputy General Manager
- 698.70K
- xuesong yu
- Directors, Deputy General Manager, Chief Financial Officer
- 608.20K
- yong yang
- Directors
- 512.00K
- qin tang
- Directors, Board Secretary
- 607.50K
- lu wang
- Directors, General Manager, Strategy Committee Members
- 776.20K
- zhiqiang liu
- Independent Directors, Audit Committee Member, Strategy Committee Member, Chairman of the Nomination Committee
- --
- zhi dong
- Independent Directors, Nomination Committee Members, Strategy Committee Member, Chairman of the Remuneration and Assessment Committee, Audit Committee Member
- 8.30K
- geng chen
- Independent Directors, Chairman of the Audit Committee, Member of the Remuneration and Assessment Committee, Strategy Committee Members
- 60.00K
- yadong tao
- Securities Affairs Representative
- --
- shanyan wu
- Chairman of the Supervisory Board, Auditors
- 160.80K
- ziwei guo
- Auditors
- 613.20K
- jing feng
- Deputy General Manager
- 608.20K
- wei wang
- Deputy General Manager
- 631.50K
- haili zhu
- Head of Audit Department
- --
- yifeng xu
- Employee Supervisors
- --
No Data
